Levita Magnetics, a company offering magnetic assistance in minimally invasive surgery, today announced FDA clearance of its Magnetic Surgical System (MSS) for pediatric patients.
The company said surgeons at Cleveland Clinic Children's have successfully completed the first pediatric procedure in the U.S. using Levita's MARS System in combination with the FDA-cleared MSS for laparoscopic cholecystectomy.
The technology uses external magnets to control internal surgical instruments, reducing the number of incisions typically required in laparoscopic procedures.
The MARS System combines surgical precision with Levita's proprietary Dynamic Magnetic Positioning technology to reduce the number of incisions in laparoscopic procedures. By using magnetic retraction of organs and soft tissue—rather than additional fixed ports—the system enhances visualization and control while significantly reducing surgical trauma.
